Skip to main content

olmesartan medoxomil

NDC 50090-3487 · A-S Medication Solutions

Generic nameolmesartan medoxomil
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)OLMESARTAN MEDOXOMIL
Strength40 mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
Marketing categoryANDA

Packages

50090-3487-0 — 30 TABLET, FILM COATED in 1 BOTTLE (50090-3487-0)

50090-3487-1 — 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-3487-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

46708-215 — Amlodipine besylate and Olmesartran medoxomil, 49252-065 — olmesartan medoxomil, 49252-066 — olmesartan medoxomil, 49252-067 — OLMESARTAN MEDOXOMIL, 49884-786 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 49884-787 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 49884-788 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 49884-789 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 49884-790 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 50090-3471 — olmesartan medoxomil, 50090-3561 — Olmesartan Medoxomil and Hydrochlorothiazide, 50090-3655 — Olmesartan Medoxomil, 50090-3656 — Olmesartan Medoxomil, 50090-3701 — Olmesartan Medoxomil and Hydrochlorothiazide, 50090-4377 — Olmesartan Medoxomil and Hydrochlorothiazide, 50090-4451 — Olmesartan Medoxomil, 50090-5402 — OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, 50090-5450 — Olmesartan Medoxomil and Hydrochlorothiazide, 50090-6606 — olmesartan medoxomil, 50090-6632 — Olmesartan medoxomil, +281 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels